Skip to main content

Advertisement

SpringerLink
Log in

Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Nuclear factor-kappa B (NF-κB), a cell survival signal, is involved in carcinogenesis. Polymorphism of NF-κB1 is associated with cancer by several studies. This study aims to perform a comprehensive meta-analysis of studies and determine the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer. Twenty-five case–control studies (7,281 cases and 10,039 controls) were included. We used odds ratios (ORs) to assess the strength of the association, and 95 % confidence intervals (CIs) to identify precision of the estimate. Overall, NF-κB1-94ins/del ATTG promoter polymorphism was significantly associated with decreased susceptibility to cancer in overall population under homozygote (for DD vs. WW: OR = 0.74, 95 % CI = 0.58–0.96), recessive (for DD vs. WD+WW: OR = 0.82, 95 % CI = 0.69–0.99), dominant (for DD+WD vs. WW: OR = 0.84, 95 % CI = 0.71–1.00), and allele (for D vs. W: OR = 0.88, 95 % CI = 0.78–0.98) model. Subgroup analysis for ethnicity found that NF-κB1-94ins/del ATTG promoter polymorphism was significantly associated with decreased susceptibility to cancer in Asians (for DD vs. WW: OR = 0.54, 95 % CI = 0.40–0.74; for WD vs. WW: OR = 0.75, 95 % CI = 0.69–0.81; for DD vs. WD+WW: OR = 0.70, 95 % CI = 0.55–0.90; for DD+WD vs. WW; OR = 0.66, 95 % CI = 0.56–0.78; for D vs. W: OR = 0.75, 95 % CI = 0.65–0.86), but the association was not found in Caucasians. The findings suggest that NF-κB1-94ins/delATTG promoter polymorphism is significantly associated with decreased susceptibility to cancer in overall and Asian population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer. 2010;10:484.

    Article  Google Scholar 

  2. Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol. 1997;29:867–70.

    Article  CAS  Google Scholar 

  3. Beinke S, Ley SC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J. 2004;382:393–409.

    Article  CAS  Google Scholar 

  4. Bu H, Rosdahl I, Sun XF, Zhang H. Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol. 2007;133:859–66.

    Article  CAS  Google Scholar 

  5. Burnik FS, Yalcin S. NFKB1-94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy. 2009;55:381–5.

    Article  CAS  Google Scholar 

  6. Cai H, Sun L, Cui L, Cao Q, Qin C, et al. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma. Urol Int. 2013;91:206–12.

    Article  CAS  Google Scholar 

  7. Cheng CW, Su JL, Lin CW, Su CW, Shih CH, et al. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS ONE. 2013;8:e56130.

    Article  CAS  Google Scholar 

  8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  Google Scholar 

  9. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  Google Scholar 

  10. Fan Y, Yu W, Ye P, Wang H, Wang Z, et al. NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA Cell Biol. 2011;30:241–5.

    Article  CAS  Google Scholar 

  11. He Y, Zhang H, Yin J, Xie J, Tan X, et al. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis. 2009;30:1916–22.

    Article  CAS  Google Scholar 

  12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  Google Scholar 

  13. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004;13:35–45.

    Article  CAS  Google Scholar 

  14. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431–6.

    Article  CAS  Google Scholar 

  15. Kim U, Gunther CS, Roeder RG. Genetic analyses of NFKB1 and OCA-B function: defects in B cells, serum IgM level, and antibody responses in Nfkb1−/−Oca-b−/− mice. J Immunol. 2000;165:6825–32.

    Article  CAS  Google Scholar 

  16. Koti M, Gooding RJ, Nuin P, Haslehurst A, Crane C, et al. Identification of the IGF1/PI3K/NFkB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer. BMC Cancer. 2013;13:549.

    Article  Google Scholar 

  17. Lewander A, Butchi AK, Gao J, He LJ, Lindblom A, et al. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol. 2007;42:1332–8.

    Article  CAS  Google Scholar 

  18. Li P, Gu J, Yang X, Cai H, Tao J, et al. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population. PLoS ONE. 2013;8:e71604.

    Article  CAS  Google Scholar 

  19. Lin CW, Hsieh YS, Hsin CH, Su CW, Lin CH, et al. Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS ONE. 2012;7:e35078.

    Article  CAS  Google Scholar 

  20. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, et al. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett. 2006;243:47–54.

    Article  CAS  Google Scholar 

  21. Lo SS, Chen JH, Wu CW, Lui WY. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery. 2009;145:280–5.

    Article  Google Scholar 

  22. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  Google Scholar 

  23. Mathew S, Murty VV, Dalla-Favera R, Chaganti RS. Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization. Oncogene. 1993;8:191–3.

    CAS  PubMed  Google Scholar 

  24. Mayo MW, Baldwin AS. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta. 2000;1470:M55–62.

    CAS  PubMed  Google Scholar 

  25. Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, et al. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013;37:634–8.

    Article  CAS  Google Scholar 

  26. Oltulu YM, Coskunpinar E, Ozkan G, Aynaci E, Yildiz P, et al. Investigation of NF-kappaB1 and NF-kappaBIA gene polymorphism in non-small cell lung cancer. Biomed Res Int. 2014;2014:530381.

    Article  CAS  Google Scholar 

  27. Pharoah PD, Dunning AM, Ponder BA, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer. 2004;4:850–60.

    Article  CAS  Google Scholar 

  28. Riemann K, Becker L, Struwe H, Nuckel H, Duhrsen U, et al. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics. 2006;16:783–8.

    Article  CAS  Google Scholar 

  29. Riemann K, Becker L, Struwe H, Rubben H, Eisenhardt A, et al. Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther. 2007;45:423–30.

    Article  CAS  Google Scholar 

  30. Salim PH, Jobim M, Bredemeier M, Chies JA, Brenol JC, et al. Interleukin-10 gene promoter and NFKB1 promoter insertion/deletion polymorphisms in systemic sclerosis. Scand J Immunol. 2013;77:162–8.

    Article  CAS  Google Scholar 

  31. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46:705–16.

    Article  CAS  Google Scholar 

  32. Song S, Chen D, Lu J, Liao J, Luo Y, et al. NFkappaB1 and NFkappaBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS ONE. 2011;6:e21726.

    Article  CAS  Google Scholar 

  33. Tang T, Cui S, Deng X, Gong Z, Jiang G, et al. Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol. 2010;29:9–12.

    Article  Google Scholar 

  34. Ungerback J, Belenki D, Jawad ul-Hassan A, Fredrikson M, Fransen K, et al. Genetic variation and alterations of genes involved in NFkappaB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis. 2012;33:2126–34.

    Article  Google Scholar 

  35. Wang X, Lu P, Xu L, Xu Y, Shi Z, et al. Updated meta-analysis of NFkappaB1 -94ins/Delattg promoter polymorphism and cancer risk based on 19 case–control studies. Asia Pac J Cancer Prev. 2011;12:2479–84.

    Google Scholar 

  36. Zhang P, Wei Q, Li X, Wang K, Zeng H, et al. A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet. 2009;191:73–7.

    Article  CAS  Google Scholar 

  37. Zhou B, Qie M, Wang Y, Yan L, Zhang Z, et al. Relationship between NFKB1-94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol. 2010;21:506–11.

    Article  CAS  Google Scholar 

  38. Zhou B, Rao L, Li Y, Gao L, Wang Y, et al. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett. 2009;275:72–6.

    Article  CAS  Google Scholar 

  39. Zhou B, Rao L, Peng Y, Wang Y, Li Y, et al. Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy. BMC Med Genet. 2009;10:47.

    Article  Google Scholar 

  40. Zou YF, Wang F, Feng XL, Tao JH, Zhu JM, et al. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Tissue Antigens. 2011;77:9–17.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Science and technology project of Tianjin Municipal Health Bureau (NO: 11KG147, 12ZCDZSY16600, 12 ZCDZSY16900, 10SYSYJC28700).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Urology, Tianjin Institute of Urology, National Key Clinical Specialty of Urology, Tianjin Key Lab of Urology, The Second Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin, 300211, China

    Xuewu Nian, Wei Zhang, Limin Li, Yan Sun, Erlin Sun & Ruifa Han

Authors
  1. Xuewu Nian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Limin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erlin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ruifa Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Erlin Sun or Ruifa Han.

Additional information

Xuewu Nian and Wei Zhang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nian, X., Zhang, W., Li, L. et al. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer. Tumor Biol. 35, 11921–11931 (2014). https://doi.org/10.1007/s13277-014-2470-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2470-3

Keywords

Search

Navigation